A population-based study of measles, mumps, and rubella vaccination and autism;MFR-vaccination og autisme - Et populationsbaseret followupstudie

Ugeskrift for Laeger

Volumn 164, Issue 49, 2002, Pages 5741-5744

  Madsen, Kreesten Meldgaard ^a   Hviid, Anders ^b   Vestergaard, Mogens ^b   Schendel, Diana ^b   Whlfahrt, Jan ^b   Thorsen, Poul ^b   Olsen, Jørn ^b   Melbye, Mads ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AGE; ARTICLE; AUTISM; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA ANALYSIS; DENMARK; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; INFANT; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PRESCHOOL CHILD; REGISTRATION; RETROSPECTIVE STUDY;

AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; RETROSPECTIVE STUDIES; RISK ADJUSTMENT;

EID: 0037011202     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. California's Department of Developmental Services HaHSA. Changes in the Population of Persons with Autism and Pervasive Developmental Disorders in California's Developmental Services System: 1987 through 1998. A Report to the Legislature, 2001. California Health and Human Services Agency. State of California.
2. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev 2000; 19: 265-83.
3. Autism - present challenges, future needs - why the increased rates? [106th Congress]. U.S. House Committee of Government Reform, 2000.
4. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41.
5. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002; 55: 84-90.
6. Singh VK, Lin SX, Newell E, Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 2002; 9: 359-64.
7. Johnson RT, Griffin DE, Hirsch RL, Wolinsky JS, Roedenbeck S, Lindo de Soriano I et al. Measles encephalomyelitis - Clinical and immunologic studies. N Engl J Med 1984; 310: 137-41.
8. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J et al. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. Lancet 1999; 353: 2026-9.
9. Kaye JA, Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BMJ 2001; 322: 460-3.
10. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA 2001; 285: 1183-5.
11. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001; 108: E58.
12. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351: 1327-8.
13. Taylor B, Miller E, Lingram L, Andrews N, Simmons A, Stowe J. Measles, mumps, and rebella vaccination and bowel problems or developmental regression in children with autism: Population study. BMJ 2002; 324: 393-6.
14. Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsopp M, Decoufle P. Prevalence of autism in a United States population: The brick township, new jersey, investigation. Pediatrics 2001; 108: 1155-61.
15. Vellinga A, Depoorter AM, van Damme P. Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium. Acta Paediatr 2002; 91: 599-603.
16. Epidemiology and Prevention of Vaccine-Preventable Diseases. 7th Edition. Maryland: Public Health Foundation, 2002.
17. Burd L, Fisher W, Kerbeshian J. A prevalence study of pervasive developmental disorders in North Dakota. J Am Acad Child Adolesc Psychiatry 1987; 26: 700-3.
18. Baird G, Charman T, Baron-Cohen S, Cox A, Swettenham J, Wheelwright S et al. A screening instrument for autism at 18 months of age: A 6-year follow-up study. J Am Acad Child Adolesc Psychiatry 2000; 39: 694-702.
19. Fombonne E, Du MC, Cans C, Grandjean H. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 1997; 36: 1561-9.
20. Croen L, Grether J, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002; 32: 207-15.